Company Update: Pfizer Inc (NYSE:PFE) – Teva settles patent suit with Pfizer over Celebrex

[Reuters] – Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc’s blockbuster painkiller Celebrex in December. A U.S. court in March invalidated . . . → Read More: Company Update: Pfizer Inc (NYSE:PFE) – Teva settles patent suit with Pfizer over Celebrex Similar Articles: Company Update (NYSE:PFE): Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN® In Very Young Children Born Small For Gestational Age Pfizer Inc (NYSE:PFE) | Pfizer Invites Public To View And Listen To Webcast Of May 5 Conference Call With Analysts Market Update (NYSE:PFE): Pfizer Launches 2013 Integrated Annual Review
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.